3-[8-(chloromethyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-7-yl]propanenitrile CAS 1170464-17-1
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 1170464-17-1 |
| Molecular Formula | C10H10ClN5O2 |
| Molecular Weight | 267.67 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
3-[8-(chloromethyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-7-yl]propanenitrile (CAS 1170464-17-1) is a high-purity pharmaceutical standards reference standard from CATO, an ISO 17034 accredited reference material producer. Molecular formula: C10H10ClN5O2. Molecular weight: 267.67 g/mol. Each batch is supplied with a Certificate of Analysis (COA).
Physical & Chemical Properties
| Molecular Formula | C10H10ClN5O2 |
| Molecular Weight | 267.67 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, faint amine-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1989 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 5 |
Related chloromethyl Standards
- (4E)-3-(Chloromethyl)-4-(4-hydroxy-2-methoxybenzylidene)isoxazol-5(4H)-one (CAS 1142199-55-0)
- 2-(Chloromethyl)-6-(trifluoromethylthio)benzo[d]oxazole (CAS 1803884-25-4)
- 2-(Chloromethyl)-4-(trifluoromethylthio)benzo[d]oxazole (CAS 1806326-64-6)
- 5-Chloromethyl-2-piperidin-1-yl-4H-[1,2,4]-triazolo[1,5-a]pyrimidin-7-one (CAS 1019111-22-8)
- 4-(Chloromethyl)-2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazole (CAS 1048918-49-5)
- 1048920-87-1 4-(Chloromethyl)-2-(2,3-dimethoxyphenyl)-5-methyl-1,3-oxazole MFCD09759011 (CAS 1048920-87-1)
- 4-(Chloromethyl)-2-(3,4-dimethoxyphenyl)-5-methyloxazole (CAS 907200-66-2)
- 4-[2-(chloromethyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]morpholine (CAS 99839-96-0)
Recommended Standards
- Ethyl (5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)carbamate (CAS 116221-81-9)
- 6-(4-Chloro-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2h)-one (CAS 117397-88-3)
- 5-[(4-amino-2-chlorophenoxy)methyl]-2-furoic acid (CAS 1245808-08-5)
- 1-[(3-methylphenyl)methyl]piperidine-2-carboxylic acid hydrochloride (CAS 1258647-69-6)
- Lacto-N-difucohexaose I (CAS 16789-38-1)
- (S)-3-amino-2-(4-hydroxybenzyl)propanoic acid (CAS 1190597-08-0)
- [(R)-1-(2-Amino-acetyl)-piperidin-3-yl]-methyl-carbamic acid tert-butyl ester (CAS 1354016-07-1)
- 4-Isopropylpicolinonitrile (CAS 676136-14-4)
- 5-(Aminomethyl)-4-cyclopropoxypicolinaldehyde (CAS 1243468-95-2)
- Calcitonin C-Terminal Flanking Peptide (human) XTFA (CAS 85916-47-8（free base）)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com